BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Pillar Centre | The Mater Hospital - ECPv6.1.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Pillar Centre | The Mater Hospital
X-ORIGINAL-URL:https://thepillarcentre.ie
X-WR-CALDESC:Events for The Pillar Centre | The Mater Hospital
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210323T180000
DTEND;TZID=UTC:20210323T203000
DTSTAMP:20260405T124820
CREATED:20210318T163512Z
LAST-MODIFIED:20210318T164055Z
UID:5506-1616522400-1616531400@thepillarcentre.ie
SUMMARY:Inaugural IPOMS Webinar Launch
DESCRIPTION:The Irish Perioperative Medicine Society is delighted to present the Inaugural IPOMS Webinar Launch \nIPOMS Flyer FINAL\n  \nRegister for FREE here: https://registration.ipoms.org \n  \n2 CPD points awarded from the College of Anaesthesiologists of Ireland (CAI)
URL:https://thepillarcentre.ie/events/inaugural-ipoms-webinar-launch/
CATEGORIES:AGM,Webinar
ATTACH;FMTTYPE=image/jpeg:https://thepillarcentre.ie/wp-content/uploads/2021/03/IPOMS.jpg
ORGANIZER;CN="Irish%20Perioperative%20Medicine%20Society":MAILTO:irishpoms@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201002
DTEND;VALUE=DATE:20201003
DTSTAMP:20260405T124820
CREATED:20201002T090031Z
LAST-MODIFIED:20201004T130252Z
UID:4856-1601596800-1601683199@thepillarcentre.ie
SUMMARY:VTE Dublin 2020
DESCRIPTION:Diagnostic and therapeutic advances in venous thromboembolism (VTE)\nOpening Address: Prof Fionnuala Ní Áinle\, Consultant Haematologist\, MMUH/Rotunda Hospitals \nSession 1\n\n\n\nTime\nTalk\nPresenter\nAbout the Presenter\n\n\n09:00-09:30\nDirect thrombus imaging: the future looks bright\nDr Erik Klok\nDept of Thrombosis and Haemostasis\, Leiden University Medical Centre\, Leiden\, The Netherland; visiting Professor\, Center for Thrombosis and Hemostasis\, Mainz\, Germany\n\n\n09:30-10:00\nEnoxaparin for Primary Thromboprophylaxis in Symptomatic Ambulatory Patients With\nCOVID-19: the Randomized Controlled Trial OVID\nDr Stefano Barco\nStaff Physician\, Clinic of Angiology\, Zurich\, Switzerland\n\n\n09:30-10:00\nHYPATIA: a randomised controlled trial in pregnant women with antiphospholipid antibodies\nDr Karen Schrieber\nDanish Hospital for Rheumatic disease in Sonderburg\, Denmark\n\n\n09:30-10:00\nCoffee\n\n\n\n\n09:30-10:00\nThe Patient Experience\nMs Ann-Marie O’ Neill\nThrombosis Ireland\n\n\n\nSession 2\n\n\n\nTime\nTalk\nPresenter\nAbout the Presenter\n\n\n11:30-12:00\nCovid-19 coagulopathy and thrombosis: Novel prognostic and therapeutic opportunities: The COCOON study\nDr Barry Kevane\nConsultant Haematologist\, Mater Misericordiae University Hospital\, Dublin\n\n\n12:00-12:30\nVTE & Immunothrombosis; Where do we go from here?\nProfessor Beverley Jane Hunt OBE\nProfessor of Thrombosis & Haemostasis at King’s College London; Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP\n\n\n12:30-13:00\nCOVID-19: clinical pitfalls in the ICU\nProf Jan Beyer Westendorf\nHead of Division “Thrombosis Research”\, Medical Clinic III Dresden University Clinic\n\n\n13:00-13:30\nDr Clive Kearon Memorial Lecture\nImproving the diagnosis of pulmonary embolism in the emergency Department.\nDr Kerstin de Wit\nAssistant Professor\, Division of Emergency Medicine\, Department of Medicine; Emergency Medicine and Thrombosis Physician\, Hamilton Health Science\, Ontario\, Canada\n\n\n13:30-14:00\nLunch\n\n\n\n\n\nSession 3\n\n\n\nTime\nTalk\nPresenter\nAbout the Presenter\n\n\n14.00-14:30\nAnticoagulation for COVID-19\nDr Michelle Sholzberg\nDivision Head of Hematology-Oncology\, Medical Director of the Coagulation Laboratory\, Director of the Hematology-Oncology Clinical Research Group\, St. Michael’s Hospital\, Li Ka Shing Knowledge Institute\, University of Toronto\n\n\n14:30-15:00\nComparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The COBRRA study\nDr. Lana Castellucci\nAssistant Professor\, Division of Hematology\, Department of Medicine\, University of Ottawa. Scientist\, Clinical Epidemiology Program\, Ottawa Hospital Research Institute\n\n\n15:00-15:30\nThe Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PARTUM)\nDr Leslie Skeith\nDivision of Hematology Department of Medicine\, University of Calgary \, Calgary\, Canada\, CanVECTOR Research Network\n\n\n15:30-16:00\nVTE in COVID-19: the Boston experience\nDr Rachel Rosovsky\nDirector\, Thrombosis Research\, Division of Hematology\, Massachusetts General Hospital\, Co-Chair of MGH’s Thrombosis Committee and Assistant Professor of Medicine\, Harvard Medical School\n\n\n16:30-16:45\nClose\n\n\n\n\n\nProgramme OutlineClick to download the programmeDownload\nThis meeting is kindly supported by the Mater Postgraduate centre with unrestricted educational support from Leo Pharma\, Sanofi\, BMS and Bayer
URL:https://thepillarcentre.ie/events/vte-dublin-2020/
LOCATION:The Pillar Centre\, Mater Misericordiae University Hospital\, Eccles St\, Northside\, Dublin 7\, D07 R2WY\, Ireland
CATEGORIES:AGM
END:VEVENT
END:VCALENDAR